IP Verse

Progesterone Formulations - EP2861234

The patent EP2861234 was granted to Therapeuticsmd on Mar 27, 2019. The application was originally filed on Jun 18, 2013 under application number EP13807121A. The patent is currently recorded with a legal status of "Revoked".

EP2861234

THERAPEUTICSMD
Application Number
EP13807121A
Filing Date
Jun 18, 2013
Status
Revoked
Dec 17, 2021
Grant Date
Mar 27, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

RIECKDec 23, 2019FUCHS PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTGB1589946
INTERNATIONAL-SEARCH-REPORTUS2004052824
INTERNATIONAL-SEARCH-REPORTUS4196188
INTERNATIONAL-SEARCH-REPORTUS6294192
OPPOSITIONUS2004052824
OPPOSITIONUS2011312928
OPPOSITIONWO0207712
OPPOSITIONWO2007050574
OPPOSITIONWO2008057363
OPPOSITIONWO2010117873
OPPOSITIONWO2013078422
SEARCHUS2003077297
SEARCHUS2004052824
SEARCHUS2010255085
SEARCHUS2011312928
SEARCHUS6294192
SEARCHWO2013078422

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "A basic guide to particle characterization", Malvern Instruments worldwide, White paper, (2015), XP055657885-
OPPOSITION- FITZPATRICK, LORRAINE A. et al., "Micronized progesterone: clinical indications and comparison with current treatments", Fertility and sterility, (19990000), pages 389 - 397-
OPPOSITION- LIU, RON., "Emulsions, Microemulsions and Lipid-based Drug Delivery Systems for Drug Solubilization and Delivery - Part II: Oral Applications", Water-insoluble drug formulation, (20000000), vol. 11, pages 227 - 254, XP055466108-
OPPOSITION- LIU, RON., Water-insoluble drug formulation, (20000000), page 205-
OPPOSITION- "Medium-chain Triglycerides", page 429-
OPPOSITION- MONASTRA, G. et al., "Vitamin D: a steroid hormone with progesterone-like activity", Eur Rev Med Pharmacol Sci, (20180000), vol. 22, no. 8, pages 2502 - 2512, XP055679171-
OPPOSITION- "Polyoxyethylene Castor Oil Derivatives", page 542-
OPPOSITION- Technical data sheet of Phosal 53 MCT, (20070200), URL: http://www. american lecithin.com/TDS/TDS_53MCT.PDF, (20191115), XP002601344-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents